The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma

SIMPLE SUMMARY: Despite the recent success of immunotherapy in the treatment of malignant melanoma, many patients still do not benefit from these treatments, due to their failure to activate an antitumor immune response them. There is therefore a need to select patients who can truly benefit from th...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancers (Basel)
Κύριοι συγγραφείς: Scognamiglio, Giosuè, Capone, Mariaelena, Sabbatino, Francesco, Di Mauro, Annabella, Cantile, Monica, Cerrone, Margherita, Madonna, Gabriele, Grimaldi, Antonio Maria, Mallardo, Domenico, Palla, Marco, Sarno, Sabrina, Anniciello, Anna Maria, Di Bonito, Maurizio, Ascierto, Paolo Antonio, Botti, Gerardo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: MDPI 2021
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150779/
https://ncbi.nlm.nih.gov/pubmed/34066146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102325
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια